Stonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q425

Stonegate Capital Partners recently updated its coverage on Aemetis, Inc. (NASDAQ: AMTX), highlighting the company’s significant progress as it transitions from a capital-intensive buildout to a monetizable low-carbon fuels platform. In its Q4 2025 results, Aemetis demonstrated strong growth, particularly in its Dairy RNG segment. The company reported 12 operating digesters with an impressive annual production of approximately 405,000 MMBtu, reflecting a substantial 61% year-over-year increase in Q4 output. This growth has positioned Aemetis not just as a future potential but as an active player generating profitability, illustrated by its $10.3 million in production tax credits and $12.2 million in net income from the biogas segment during the fourth quarter.

Key factors driving Aemetis’ growth include the monetization of RNG molecule sales, D3 RINs, LCFS credits, and federal production tax credits. Additionally, the company has improved its average RNG carbon intensity significantly from a negative-150 default to negative 380, aided by seven new CARB pathway approvals.

Stonegate’s analysis suggests that Aemetis has a median valuation target of $11.7 per share, indicating considerable upside potential from current trading levels. As the company scales its Dairy RNG production and enhances its ethanol economics, it is on the verge of transitioning to sustained operating cash flow growth.

The integrated platform of Aemetis facilitates multiple revenue streams through Dairy RNG, low-carbon ethanol, and SAF optionality, further enhancing its financial outlook. This multifaceted approach is establishing Aemetis as a burgeoning leader in the low-carbon fuels market.

**Market Advice: Analyzing Stonegate Capital Partners' Update on Aemetis, Inc. (AMTX)**

As Aemetis, Inc. (NASDAQ: AMTX) advances from a capital-intensive buildout phase toward a monetizable low-carbon fuel platform, the latest coverage update from Stonegate Capital Partners signals a significant inflection point for investors. With the company reporting robust 4Q25 results, including a notable 61% year-over-year increase in biogas output and substantial contributions from production tax credits, Aemetis is demonstrating tangible profitability in their renewable natural gas (RNG) segment.

The standout performance, particularly from dairy RNG, underlines Aemetis' capability to extract value from existing assets, further solidified by favorable CARB pathway approvals that enhance carbon intensity and open new avenues for revenue. Moreover, with a median valuation target projected at $11.7 per share, Stonegate posits substantial upside from its current trading levels, suggesting that now may be a prime opportunity for investors to engage with AMTX.

Transitioning to profitability echoes a broader theme in the renewable energy space where companies building strong, integrated platforms that capitalize on fuel sales, Renewable Identification Numbers (RINs), Low Carbon Fuel Standard (LCFS) credits, and 45Z tax incentives stand to gain significant market advantage. Aemetis is well-positioned with its diverse range of offerings, extending from low-carbon ethanol to Sustainable Aviation Fuel (SAF) optionality.

Investors should approach Aemetis with a cautious optimism, considering both the evident momentum in its earnings base and the overall shift towards low-carbon fuel solutions. The recent updates point to a strong potential for sustained operating cash flow growth, encouraging long-term investment strategies as the company solidifies its position in the burgeoning green energy sector. In summary, Aemetis presents both a growth opportunity and a diversification play for investors interested in the future of sustainable energy.